Drug factory · FDA FEI 3018360274

Chengdu Shuode Pharmaceutical Co.,Ltd

No. 9 Lekang Road, Shuangliu District, Chengdu, China

China: 1

No problems found at FDA's last inspection, May 22, 2025.

No Action Indicated: inspectors found no objectionable conditions.

1 drug inspection on record since 2025: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Methylene Blue CationMakes it Chengdu Shuode Pharmaceutical Co., Ltd, Glenmark Pharmaceuticals Inc., USA 82432-104, 68462-698
NalmefeneMakes it Chengdu Shuode Pharmaceutical Co., Ltd 82432-101, 82432-102
NicardipineMakes it Chengdu Shuode Pharmaceutical Co., Ltd, Fresenius Kabi USA, LLC 82432-103, 65219-818

FDA inspection history

EndedResultProgramProblems noted
May 22, 2025No problems foundBioresearch Monitoring—

Registered with FDA for: manufacture.